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Introduction
An implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) have been shown to reduce mortality in patients at high risk for ventricular tachycardia or fibrillation (VT or VF). [1] [2] [3] [4] However, many patients experience inappropriate defibrillator therapy, defined as therapy delivered for a non-ventricular arrhythmia. Inappropriate shocks have been associated with reduced quality of life, 5, 6 myocardial injury, [7] [8] [9] rare fatal proarrhythmia, 10 and increased mortality in some studies, [11] [12] [13] whereas in other studies, no association between mortality and inappropriate shocks has been found. [14] [15] [16] Whether inappropriate shocks are causally related to increased mortality or indirectly related to mortality by the supraventricular arrhythmias triggering them, [16] [17] [18] has been difficult to establish. [11] [12] [13] [14] 19 Increasingly, device therapy programming considerations have emphasized antitachycardia pacing (ATP). 20 While ATP may reduce shocks, and improve quality of life, the effect of ATP on mortality, if any, remains unknown.
21
In the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy 22, 23 (MADIT-RIT) study, we investigated the effect of two novel ICD programming strategies on inappropriate therapy. Randomization of patients to high-rate ICD device programming with ICD therapy beginning at 200 beats per minute (bpm) or to delayed programming (12-60 seconds before ATP or shock) was associated with reductions in inappropriate therapy when compared to conventional programming. Mortality was higher with conventional programming than in the other two programming arms. In the current MADIT-RIT sub-study, we investigated the factors associated with mortality in the three treatment arms of this randomized trial. Based on potentially harmful consequences of inappropriate therapies, we hypothesized that the higher mortality rate seen with conventional programming was due in part d. 14 16 Whether irectl l l ly y y re rel la l late te t t d d d d to t to t mo mo mo mort rt r 16 18 11 14 l a T A t he M lticenter A tomatic Defibrillator Implantation Trial Red ce Inappropriate rave ve ve vent nt nt ntri ri ri ricu cu u ula la la ar ar ar ar rr r rhythmias triggering them, m, m, 16 16 16-18 has been n n dif f f ffi fi ficult to establish. f f f f f [11] [12] [13] [14] ly y y y, d d de d vice ther rap py pr p progra ra ram m mmin in in i g c cons sid d derat ati ions n ns h h hav a av a e em em emphas asized ed ed e anti ti ti ita a achy hycard rd rdia TP). 20 20 20 2 Wh Wh Wh Whi i ile AT AT AT A P P P P may redu du du duc c ce sho ho ock ck ck cks, s s, and d d i i imp mp mpro ro ro rove e e qua a ali li li l ty y of f f f life f f , th th th the ef f ff f fe t t ct of f f f A A A A ty y y, if if if i any y y, rema ma ma ains unk k known. 21 1 h h M M lt lti ic t te A A t to ti ti D Defi fib bril ill lat to I Im l pl t tati ti T T i ri l al R R d ed I In i ri t at to the high frequency of inappropriate ICD therapies in this treatment arm when compared to the other two treatment arms. and Zone 3 treated VT/VF above 250 bpm after a 2.5 sec. delay. Atrial discriminators were turned "on" in all arms. For the conventional and high-rate programming arms, onset and stability detection were used, whereas in the delayed programming arm Rhythm ID detection algorithms were used. Physician investigators were encouraged to follow optimal pharmacological treatment for the enrolled patients according to current guidelines. 25 The protocol allowed reprogramming of the devices after an inappropriate ICD therapy.
Methods
MADIT-RIT randomization, programming and interrogation
MADIT-RIT
Device interrogations were conducted every three months the first year and every six months The MADIT-RIT study was approved by an institutional review committee and all patients gave informed consent before being enrolled in the study.
End points
The primary end point of MADIT-RIT was first occurrence of inappropriate therapy; all-cause mortality was a secondary end point. 22, 23 For the current analysis, all-cause mortality was utilized as the primary end point. An independent morbidity and mortality committee adjudicated and classified deaths as cardiac, non-cardiac or unknown based on an assessment of all the information provided by the enrolling centers, including; medical history, description of the circumstances surrounding the death from family members and/or hospital personnel, the physician's determination of the cause of death, death records and when available post-mortem ICD interrogation.
ICD therapy and arrhythmia definitions
All ICD therapies from in-clinic and available post-mortem interrogations (18 of 71 death, 25%)
were adjudicated by an independent device interrogation committee. Appropriate ICD therapy was defined as any ICD therapy rendered for VT or VF. Inappropriate ICD therapy was defined as any ICD therapy delivered where VT or VF was not present. 22 Appropriate and inappropriate ICD therapies were subdivided as ATP or shock. If both ATP and shock occurred in an episode it was considered a shocked episode.
Pharmacotherapy
Cardiovascular pharmacotherapy, including beta-blockers, statins, diuretics, digitalis, cause mortality y wa wa a as s s s ality co comm mmit it it itt te te t e e ad ad ad adju ju ju jud d pharmacotherapy on all-cause mortality was investigated by incorporating either baseline or intrial use into multivariate Cox proportional-hazard regression models. Time-dependent pharmacotherapy throughout the study period was adjusted for by creating variables for each drug taking into account the time each patient was either "on" or "off" the specific drug.
Statistics
Baseline characteristics were compared between patients who died and survivors. Comparisons between groups used chi-square or Fisher's exact tests for categorical variables, and Wilcoxon rank-sum test for continuous measures.
The cumulative proportion of all-cause mortality was calculated using the method of Kaplan-Meier. In-trial mortality risk was analyzed in all 1500 patients by multivariate Cox proportional-hazards regression models, adjusting for baseline predictors of death found by best subset analysis, setting the limit for inclusion in the model at p<0.05. The selected model was then used to analyze the influence of: 1) ICD therapy throughout the study, 2) pharmacotherapy throughout the study, and 3) randomized programming arm on the end point of all-cause mortality.
We created time-dependent variables for appropriate shock, appropriate ATP-only, inappropriate shock, and inappropriate ATP-only. The shock and ATP-only groups were defined based on the assumption that appropriate and inappropriate ICD therapies were two different entities, and therefore any potential overlaps between appropriate and inappropriate ICD therapies were not included in the definition. Furthermore, shocks were assumed to be more detrimental than ATP, and therefore patients in the ATP-only groups were defined as ATP Hazard ratios (HR) with their 95% confidence intervals (CI) and two-sided p-values are reported. A two-tailed p-value below 0.05 was considered statistically significant.
Analyses were performed using SAS software version 9.3 (SAS Institute, Cary, NC).
Results
During a mean follow-up period of 1.4±0.6 years, 71 of 1500 (5%) enrolled patients died with 34, 16, and 21 deaths in the conventional, high-rate and delayed programming arms, respectively ( Figure 1 ). The 2.5-year cumulative probability of death was 9%. The adjudicated cause of death was cardiac in 40 patients (56.3 %), non-cardiac in 23 patients (32.4%) and unknown in 8 patients (11.3%) ( Figure 1 ). The majority of the cardiac deaths were due to heart failure (HF), closely followed by SCD (Figure 1 ). The proportions of cardiac deaths were equally distributed among the programming arms, whereas the percentage of non-cardiac deaths were higher in the l l f fo d ed i si S SAS AS ft ft re i io 9 9 3 3 (S (SAS AS I I ti tit t t te C Ca NC NC conventional and delayed programming arms compared to the high-rate programming arm. Most of the non-cardiac death in the conventional programming arm were related to cancer (n=8).
Baseline factors and all-cause mortality
Patients who died were significantly older, had lower left ventricular ejection fraction (LVEF), lower diastolic blood pressure, and were more likely to have ischemic cardiomyopathy, diabetes, and to receive amiodarone and/or digitalis at baseline than patients who survived (Table 1) .
Similarly, in multivariate analysis, older age, lower diastolic blood pressure, NYHA class III (compared to lower NYHA class), lower LVEF, ischemic cardiomyopathy, diabetes, and implantation of an ICD (compared to a CRT-D) were significantly associated with an increased risk of all-cause mortality ( Table 2) .
ICD therapy and all-cause mortality
During follow-up, appropriate ICD therapy occurred in 186 of 1500 patients (12.4%).
Inappropriate ICD therapy, largely due to atrial tachyarrhythmia, occurred in 152 of 1500 patients (10.1%). Patients in the conventional programming arm received a higher frequency of both appropriate and inappropriate therapies than patients in the other two treatment arms. Figure   2 shows the breakdown of patients who died with known antecedent appropriate or inappropriate ICD therapies.
In multivariate analyses, both appropriate and inappropriate therapies were significantly associated with increased risk of all-cause mortality (Table 3a) . Increased risk of mortality was associated with the delivery of appropriate shock, inappropriate shock, and/or inappropriate ATP-only (Table 3a) . No increased risk of mortality was found in the 112 patients who experienced appropriate ATP-only (Table 3a) . The significant associations persisted after adjustment for programming arm and time-dependent pharmacotherapy (results not shown). caus us us use e e e mo mo mo ort rt rt r al a a it t ty y y y ( Table 2) . Assessing the risk of mortality associated with ICD therapies by heart rate range revealed that inappropriate ICD therapy in the 170-199 bpm range was associated with a significantly increased risk of death, whereas appropriate ICD therapy in the same heart rate range had no associated mortality risk (Table 3b ). The risk of mortality was increased in patients who although we were unable to show an increased risk of mortality with inappropriate ICD th 200 bpm (Table 3b) . (Table 4) .
Pharmacotherapy and all-cause mortality
In multivariate analysis, after adjusting for baseline predictors of death and for ICD therapy, the 
ICD programming and all-cause mortality
Randomization to conventional programming compared to high-rate programming remained significantly associated with increased risk of mortality even after further adjustment for timedependent ICD therapies and time-dependent use of amiodarone and ACE/ARB (Table 5) . A significant mortality risk was not present when comparing conventional programming to delayed programming ( Table 5 ). The results were consistent when considering cardiac mortality (Table   5 ).
During follow-up, 166 patients (11%) deviated from the allocated randomized programming arm on the parameters of rate cut-off, delay before therapy and ATP on/off, with 70 patients randomized to conventional programming, 54 randomized to high-rate programming and 42 randomized to delayed programming. Of the patients who deviated within the above mentioned parameters only 9 patients died, with equal distribution among the programming arms (3 events in each arm).
Discussion
In the MADIT-RIT trial, randomization to conventional ICD programming, inappropriate ICD therapy, and appropriate ICD shocks were each independently associated with increased mortality risk after adjustment for relevant risk covariates.
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Several mechanisms could potentially explain the association of conventional programming to increased mortality. Inappropriate therapy may have contributed to the differential mortality rates between arms. The sum total of inappropriate and appropriate shocks in the conventional treatment arm was almost twice the number of delivered shock therapies in the high-rate and delayed-treatment arms. 23 Thus, the increased frequency of shocks in the conventional treatment arm could contribute additional myocardial injury to an already compromised myocardium with increase in the subsequent risk for heart failure and/or lifethreatening ventricular tachyarrhythmias, as previously suggested. 9 However, inappropriate ATP and/or shock therapy cannot be the only factor responsible for the increased mortality in the conventional arm. Total deaths numbered 34 in conventional, versus 16 in the high rate and 21 in the delayed therapy arm. However, the number of patients dying after experiencing a confirmed inappropriate therapy was 8 versus 0 versus 2 respectively, and therefore other factors must have contributed to the increased mortality. In multivariate analyses, when adjusted for appropriate and inappropriate therapy, assignment to conventional programming remained an independent predictor of mortality, indicating the presence of an unknown entity in patients programmed to conventional programming that contributed to increased mortality. As seen in Figure 1 , there was a sizable difference in non-cardiac deaths between the programming arms, and this was mostly due to cancer-related deaths as adjudicated by the Mortality Review Committee. Although an element of chance might be involved in the higher frequency of cancer-related deaths in the conventional programming arm, it is also possible that cancer patients are especially vulnerable to the increased occurrence of adverse appropriate and inappropriate shocks in the 170-199 bpm range potentially compromising their limited medical reserve.
Inappropriate ATP-only was very frequent in the conventional programming arm, also reported in a recent sub-study of the MADIT-CRT trial. 14 However, the mechanism by which inappropriate ATP, by itself, contributed to increased mortality risk is still unclear, since in both the current study and in MADIT-CRT trial 14 , appropriate ATP was not associated directly with any harm. In the current study, inappropriate ATP-only was not a marker for risk related to supraventricular tachyarrhythmias, since device interrogations revealed that the cumulative frequency of these arrhythmias in the 170-199 bpm range, was almost identical (21-22%) in the conventional and high-rate treatment arms. 26 Inappropriate ATP can be proarrhythmic, 27 but such episodes of direct and immediate harm were very infrequent, and no fatal ICD-proarrhythmic events 10 (from ATP or shock) were documented in MADIT-RIT. As compared with appropriate ATP, when inappropriate ATP was delivered approximately twice as many pacing sequences resulted. Given that inappropriate therapy is rarely effective in terminating the atrial arrhythmias responsible for triggering the inappropriate response, it is possible, that the larger number of sequences may have exerted an adverse influence on the myocardium. However, in summary, based on analysis of the available data, it is not currently possible to determine the mechanism by which inappropriate ATP was significantly associated with increased mortality.
Since MADIT-RIT was designed for analysis as two parallel trials, it is intriguing that both high-rate and delayed therapy intervention arms exhibited both a 75-80% lower incidence of first inappropriate therapy and also a 44-55% mortality reduction. Although the mortality difference was significant only for the conventional versus the high-rate programming arm, the results from the two arms are nevertheless mutually supportive. Moreover, the two-fold higher was almost ident tic ic ic ical a a a e AT T T TP P P P ca can n b b be be observed a 38% lower rate of delivered therapies including inappropriate shocks and appropriate ATP and shocks. However no decreased risk of mortality was found. In the MADIT-RIT trial, the total delivered therapies in the high-rate arm was 66% lower than the delivered therapies in the conventional therapy arm. 23 This difference in delivered therapies between the control and interventional arm of the two studies, as well as both the higher detection limit in the control group, and the shorter follow-up time in ADVANCE III as compared to MADIT-RIT, may explain the different findings regarding reduction in mortality between the two studies. Similar to MADIT-RIT, a trend toward mortality reduction was seen in the shock-reduction programming study PREPARE.
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Study Limitations
Since MADIT-RIT was designed to evaluate the primary end point of first inappropriate therapy, we are limited in power for secondary analysis on the end point of mortality, with relatively few mortality events in each of the programming arms over a comparatively short follow-up period (1.4±0.6 years). This is evident from the p-value when comparing conventional programming to high-rate programming (p=0.032). Given the number of statistical tests, the p-values reported should be considered as nominal and it is noted that the difference in all-cause mortality would not reach significance if we had corrected for the two comparisons A vs. B and A vs. C, although IT a trend to ard mortalit red ction as seen in the shock red ction programm tion on on onal al al l t t the he he era ra rapy y y a a a arm. 23 This difference in de de de deli l vered therap ap ap pies s s b b between the control a n n n nal l l l arm of the e t two o st t studie ie ie es, as s wel e ell as s b b both h t the e e e h h hig ig ig gher de de detect tio on n n li i imit in in in the he con on ontro it would be very close to significant (significance limit accounting for two comparisons:
In the MADIT-RI IT T T T t tr t the d d d del el li iv iv i er er d d ed ed t t the h h hera ra a ap
p<0.025, actual p-value: p=0.032). Furthermore, by utilizing the conventional programming arm as common comparator there is a risk of confounding. Secondly, the ICD device memory capacity might have led to unavailability of electrograms for some repeat arrhythmia episodes due to overwriting. 22 Third, even though adjustments for multiple baseline variables were used to investigate the association of ICD therapy and mortality, there is a possibility that other unmeasured confounders, such as differential medical or surgical management, may have affected the results. Furthermore, post-mortem interrogations were only available in 18 of 71 deaths (25%), which make it difficult to assess whether patients had ICD therapy prior to their death. This limitation might have impacted our results on an unknown level. Lastly, information regarding cancer at baseline was not reported, and cancer at baseline was not an exclusion criterion according to the protocol. Therefore there is a chance that more patients randomized to conventional programming had cancer at enrollment, as compared to patients randomized to high-rate or delayed programming, which may have contributed to the mortality difference. As previously mentioned, the cancer patients may have less medical reserve due to their chronic illness and thus may be more vulnerable to the increased occurrence of adverse appropriate and inappropriate shocks in the conventional treatment arm.
Conclusion
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